MedPath

The effect of Arnotts Vita-Weat supplementation on weight loss in overweight and obese participants.

Not Applicable
Not yet recruiting
Conditions
Overweight
Obesity
Diet and Nutrition - Obesity
Registration Number
ACTRN12614001283662
Lead Sponsor
niversity of Sydney
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not yet recruiting
Sex
All
Target Recruitment
76
Inclusion Criteria

*Aged 25-55 years
*Pre-menopausal
*BMI greater than or equal to 25 to less than or equal to 35 kg /m^2
*Regular eating habits; familiar with Vita-Weat

Exclusion Criteria

*Type 1 diabetes
*Type 2 diabetes treated with insulin
*Coeliac disease and gluten intolerance
*Previous bariatric surgery
*Untreated thyroid disease
*Greater than 10% change in body weight over the past 3 months
*Alcohol or illicit drug abuse
*Pregnant or breastfeeding women, and women who might be planning pregnancy during the duration of the study
*Use of weight loss medications and other drugs that may affect body weight e.g. anti-psychotics, anti-depressants, or corticosteroids
*A history or presence of malignancy [completely resected basal or squamous cell carcinoma of the skin if treatment completed > 6 months prior to enrolment and participants in remission for > 5 years prior to screening remain eligible]
*Inability to read and write English
*A history of frequently changing smoking habits, in addition to smoking cessation within 6 months prior to screening. Those who wish to take on the advice of a 'Quit' smoking programme at the time of screening will be eligible to start the trial after 6 months
*Participants may also be excluded, if in the opinion of the study investigators, they have some other condition or disorder that may adversely affect the outcome of the study or the safety of the participant

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To determine the efficacy of Vita-Weat food supplementation on weight loss in an overweight and obese group.<br><br>Weight loss will be assessed by comparing pre and post intervention weights obtained using calibrated scales.[Six weeks after randomisation.]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath